Abstract
Abstract:
Bladder cancer, the 10th most common cancer globally, primarily manifests as urothelial cell carcinoma. Risk factors involve acquired genetic mutations and congenital predispositions, impacting diagnosis and management. This article discusses the risk factors, clinical presentation, and treatment strategies, with emphasis on providing comprehensive nursing support and patient education to patients with bladder cancer.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference28 articles.
1. Epidemiology of bladder cancer;Saginala;Med Sci,2020
2. Pathology;Al-Ahmadie;Bladder Cancer: A Practical Guide,2021
3. Epidemiology of bladder cancer in 2023: a systematic review of risk factors;Jubber;Eur Urol,2023
4. The epidemiology of bladder cancer;Mossanen;Hematology/Oncology Clinics of North America: Bladder Cancer,2021
5. Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder;Tripathi;World J Clin Oncol,2020